ADVB Ключевая статистика
Максимум
18.73
Открыть
8.32
Объем
23.55M
Минимум
8.08
Предыдущее закрытие
7.08
Объем торгов
312.10M
Макс. 52 нед.
18.73
Отн. объем
5.794
Амплитуда (%)
150.42%
Мин. 52 нед.
3.61
Коэф. оборота
1425.97%
Рыночная капитализация
11.69M
P/E (TTM)
44.47
P/E (год.)
--
P/B
1.27
P/S
--
Прибыль на акцию (EPS)
0.159
Дивиденд (TTM)
0
Дивидендная доходность
0.00%
Акции в обращении
1.65M
Валюта
USD
ADVB Доходность цены
7 день
30 день
90 день
180 день
С начала года
1 Год
ADVB Распределение денежных потоков
ADVB Дневной объем коротких продаж
ADVB История short interest
Обзор акции ADVB
As of 2026-07-22, the Advanced Biomed Inc. (ADVB) stock price today is 12.41. Based on this price, the company has a market capitalization of $11.69M, with a P/E ratio of 44.47.
On 2026-07-22, ADVB traded between 8.08 and 18.73. Today’s stock price is 53.59% above the daily low and 33.74% below the daily high, placing ADVB примерно в середине its most recent trading range.
Trading volume currently stands at 23.55M, compared with an average daily volume of 4.06M. This suggests that trading activity is значительно выше обычного уровня than usual.
Over the past year, Advanced Biomed Inc. shares have traded between 3.61 and 18.73. At today’s price, ADVB is 243.77% above its 52-week low and 33.74% below its 52-week high.
ADVB Связанные новости
О нас ADVB
Название компании
Advanced Biomed Inc.
Сектор
Health Technology
Отрасль
Biotechnology
Биржи
Nasdaq
Количество сотрудников
31
Размер лота
100
Официальный сайт
Валюта
USD
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
Related Stocks
ADVB FAQ
© 2026 CoinGlass, all rights reserved
